Tracking and Evaluating Molecular Tumor Markers With Cancer Registry Data: HER2 and Breast Cancer

US Incidence of Breast Cancer Subtypes Defined by Joint Hormone Receptor and HER2 Status

(2014) Nadia Howlader et al.   JNCI-Journal of the National Cancer Institute

Use of Imputed Population-based Cancer Registry Data as a Method of Accounting for Missing Information: Application to Estrogen Receptor Status for Breast Cancer

(2012) Nadia Howlader et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Age-Specific Incidence of Breast Cancer Subtypes: Understanding the Black–White Crossover

(2012) Christina A. Clarke et al.   JNCI-Journal of the National Cancer Institute

Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States

(2011) Anil K. Chaturvedi et al.   JOURNAL OF CLINICAL ONCOLOGY

Incidence of Breast Cancer in the United States: Current and Future Trends

(2011) W. F. Anderson et al.   JNCI-Journal of the National Cancer Institute

Human epidermal growth factor receptor-2 and estrogen receptor expression, a demonstration project using the residual tissue respository of the Surveillance, Epidemiology, and End Results (SEER) program

(2008) W. F. Anderson et al.   BREAST CANCER RESEARCH AND TREATMENT

Breast Cancer Subtype Approximated by Estrogen Receptor, Progesterone Receptor, and HER-2 Is Associated With Local and Distant Recurrence After Breast-Conserving Therapy

(2008) Paul L. Nguyen et al.   JOURNAL OF CLINICAL ONCOLOGY